NeurAxis, Inc. (NRXS)
5.71
-0.17
(-2.89%)
USD |
NYAM |
Mar 06, 16:00
5.63
-0.08
(-1.40%)
After-Hours: 20:00
NeurAxis EPS Diluted (Quarterly) : -0.235 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Agenus, Inc. | 1.944 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
| Arrowhead Pharmaceuticals, Inc. | 0.219 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.123M |
| Revenue (Quarterly) | 0.8114M |
| Total Expenses (Quarterly) | 2.934M |
| Enterprise Value | 26.84M |
| Gross Profit Margin (Quarterly) | 83.30% |
| Profit Margin (Quarterly) | -261.6% |
| Earnings Yield | -17.91% |
| Normalized Earnings Yield | -17.92 |